ISLAMABAD (Reuters) – Pakistan has reversed a decision which had allowed uncapped prices for COVID-19 vaccines imported by private firms, Health Minister Faisal Sultan said on Thursday.
Pakistan, largely reliant on the GAVI/WHO COVAX initiative for poorer nations, had early February allowed private companies to import coronavirus vaccines and agreed to exempt such imports from price caps.
“Now, however, there is a formula, already in vogue, to determine max price,” Sultan told Reuters. “So yes, there is a price cap that DRAP (Drug Regulatory Authority of Pakistan) will recommend and get approval for,” he said.
(Reporting by Asif Shahzad; Editing by Toby Chopra)
